The Pharmacy Benefit Management Institute, a provider of research and education on drug cost management, recently awarded eight organizations for their exceptional contributions across the pharmacy management continuum. These organizations have created highly effective programs in the areas of care management strategies, cost containment, opioid management strategies, and quality improvement.
One of those winners was McKesson Ventures portfolio company Truveris, an awardee in the Cost Containment category for its TruGuard® solution for pharmacy benefit manager contract oversight and risk mitigation. Using proprietary Truveris technology, TruGuard re-adjudicates 100 percent of prescription drug claims, reviews pharmaceutical claims for accuracy, identifies clams errors and overcharges, and provides reports for demonstrating PBM performance and contract compliance.
The other winner in the Cost Containment category was Cigna, which was recognized for its multi-year effort demonstrating the value of integrated benefits—medical, pharmacy, and behavioral health—for its customers and clients.
Other winners in the PBMI Excellence Awards were:
- Care Management Strategies: Abcara’s disaster preparation and recovery program and Southwire & Premise Health’s integrated care model were the winners in this category.
- Quality Improvement: DST Health and BridgeCom won in this category for leveraging a Bridgecom software tool to dramatically improve the letter fulfillment process in place for Medicare Part D members.
- Opioid Management Strategies: OptumRx was recognized for significantly reducing excessive consumption, dispensing, and prescribing of prescription opioids, while still preserving quality of care, through its Opioid Risk Management program.
To learn more about the PBMI Excellence Awards and the companies recognized this year, read the full story here.